Skip to main content
. Author manuscript; available in PMC: 2020 Sep 17.
Published in final edited form as: Circulation. 2019 Jul 24;140(12):1031–1040. doi: 10.1161/CIRCULATIONAHA.118.036589

Figure 3. Cumulative incidence function estimates from competing risks modeling of CAD and CKD/ESRD outcomes.

Figure 3.

Test for equality across APOL1 risk allele groups CAD: p=0.56. CKD/ESRD p=5.1 × 10−4. CAD, coronary artery disease; PAD, peripheral artery disease; ESRD, end-stage renal disease